2026-08104RuleWallet

DEA Bans Risky Synthetic Drug MDMB-4en-PINACA Immediately

Published Date: 4/24/2026

Rule

Summary

Starting April 27, 2026, the DEA is officially putting MDMB-4en-PINACA—a powerful and risky chemical—into Schedule I, the strictest drug category. This means anyone making, selling, or using it will face serious legal rules and penalties. This move helps the U.S. follow international drug laws and keeps communities safer from this dangerous substance.

Analyzed Economic Effects

4 provisions identified: 1 benefits, 3 costs, 0 mixed.

MDMB-4en-PINACA placed in Schedule I

On April 27, 2026, the Drug Enforcement Administration permanently placed MDMB-4en-PINACA (including its salts and isomers) in Schedule I of the Controlled Substances Act. That means manufacture, distribution, import/export, research, or possession of MDMB-4en-PINACA without proper authorization is subject to Schedule I regulatory controls and administrative, civil, and criminal sanctions.

DEA Registration and Compliance Required

Anyone who handles MDMB-4en-PINACA (manufacture, distribute, import/export, research, chemical analysis, or possession) must register with DEA and comply with Schedule I rules starting April 27, 2026. Registered handlers must follow specific controls including security, labeling and packaging rules, quota limits, order form requirements, and recordkeeping and reporting obligations; inventories are required initially when first handling and then at least every two years.

Research Allowed With Schedule I Registration

Placement in Schedule I does not prohibit bona fide research on MDMB-4en-PINACA, but researchers must apply for and obtain Schedule I researcher registration through DEA's researcher registration program to conduct such work. The rule notes researchers wishing to study Schedule I substances may apply for permission under the schedule I researcher registration process.

DEA Certifies Minimal Small-Entity Impact

DEA certified that this final rule will not have a significant economic impact on a substantial number of small entities. DEA stated it identified one supplier in relevant industries (already DEA-registered) and found no evidence of significant diversion from legitimate suppliers.

Personalized for You

How does this regulation affect your finances?

Personalize government policy and PRIA will tell you what this federal register document means for your household, plus every other regulation we track. PRIA reads each provision against your financial profile to show you exactly what matters to your wallet.

Key Dates

Published Date
Rule Effective
4/24/2026
4/27/2026

Department and Agencies

Department
Independent Agency
Agency
Justice Department
Drug Enforcement Administration
Source: View HTML

Related Federal Register Documents

Previous / Next Documents

Back to Federal Register